Zhanel, George G. http://orcid.org/0000-0002-3238-0082
Pozdirca, Marianna
Golden, Alyssa R.
Lawrence, Courtney K.
Zelenitsky, Sheryl
Berry, Liam
Schweizer, Frank
Bay, Denice
Adam, Heather
Zhanel, Michael A.
Lagacé-Wiens, Philippe
Walkty, Andrew
Irfan, Neal
Naber, Kurt
Lynch, Joseph P. III
Karlowsky, James A.
Funding for this research was provided by:
Iterum
Article History
Accepted: 13 February 2022
First Online: 16 March 2022
Declarations
:
: George G. Zhanel has received research grants from Iterum Pharmaceuticals. Marianna Pozdirca, Alyssa Golden, Courtney K. Lawrence, Sheryl Zelenitsky, Liam Berry, Frank Schweizer, Denice Bay, Heather J. Adam, Michael A. Zhanel, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Kurt Naber, Joseph P. Lynch III and James A. Karlowsky have declared no conflicts of interest.
: The authors are grateful to Iterum Pharmaceuticals for their assistance with literature retrieval and an unrestricted research grant to aid in funding Marianna Pozdirca.
: GGZ: design and concept of the entire manuscript and drafting all sections; senior and corresponding author. MP: design and concept of the entire manuscript and drafting all sections. AG: design and concept of the entire manuscript and drafting all sections. CKL: design and concept of the entire manuscript and drafting the Pharmacokinetic/Pharmacodynamic section. SZ: design and concept of the entire manuscript and drafting the Pharmacokinetic/Pharmacodynamic section. LB: design and concept of the entire manuscript and drafting the Chemistry and Microbiology sections. FS: design and concept of the entire manuscript and drafting the Chemistry and Microbiology sections. DB: design and concept of the entire manuscript and drafting the Introduction, Mechanisms of Action and Mechanisms of Resistance sections. HJA: design and concept of the entire manuscript and drafting the Microbiology section. MAZ: design and concept of the entire manuscript and drafting the Introduction, Mechanisms of Action, Mechanisms of Resistance, Chemistry and Microbiology sections. PL-W: design and concept of the entire manuscript and drafting the Animal Models section. AW: design and concept of the entire manuscript and drafting the Clinical Trials, Adverse Effects and Place in Therapy sections. NI: design and concept of the entire manuscript and drafting the Adverse Effects, Drug Interactions and Place in Therapy sections. KN: design and concept of the entire manuscript and drafting the Clinical Trials section. JPLIII: design and concept of the entire manuscript and drafting the Clinical Trials and Place in Therapy sections. JAK: design and concept of the entire manuscript and drafting all sections.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.